Long-Term Treatment With Systemic Rifampicin and Clindamycin for Epidermal Growth Factor Receptor Inhibitor-Related Acneiform and Mucocutaneous Rash: A Valid Therapeutic Option
Long-term treatment with systemic rifampicin and clindamycin for epidermal growth factor receptor inhibitor-related acneiform and mucocutaneous rash. a valid therapeutic option / Paolino, G., Caro, R.D.C., Valenti, M., Carugno, A., Di Nicola, M.R., Cantisani, C., Mercuri, S.R., Didona, D.. - In: INTERNATIONAL JOURNAL OF DERMATOLOGY. - ISSN 0011-9059. - 65:4(2025), pp. 851-856. [10.1111/ijd.70123]
Long-term treatment with systemic rifampicin and clindamycin for epidermal growth factor receptor inhibitor-related acneiform and mucocutaneous rash. a valid therapeutic option
Paolino, Giovanni;Cantisani, Carmen;
2025
Abstract
Long-Term Treatment With Systemic Rifampicin and Clindamycin for Epidermal Growth Factor Receptor Inhibitor-Related Acneiform and Mucocutaneous Rash: A Valid Therapeutic OptionFile allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Paolino_Long‐Term_2025.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
291.94 kB
Formato
Adobe PDF
|
291.94 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
